CINQUE, FELICE
 Distribuzione geografica
Continente #
AS - Asia 1.385
NA - Nord America 1.348
EU - Europa 954
SA - Sud America 157
AF - Africa 48
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.899
Nazione #
US - Stati Uniti d'America 1.260
IT - Italia 541
SG - Singapore 402
CN - Cina 384
BD - Bangladesh 193
VN - Vietnam 135
BR - Brasile 120
HK - Hong Kong 113
RU - Federazione Russa 82
FR - Francia 63
NL - Olanda 61
CA - Canada 49
SE - Svezia 47
IN - India 39
DE - Germania 38
FI - Finlandia 30
GB - Regno Unito 29
CI - Costa d'Avorio 26
JP - Giappone 21
ID - Indonesia 18
KR - Corea 18
MX - Messico 18
ES - Italia 12
AR - Argentina 11
TW - Taiwan 11
EG - Egitto 10
PL - Polonia 10
AT - Austria 8
CO - Colombia 8
IE - Irlanda 7
IQ - Iraq 7
TR - Turchia 7
AE - Emirati Arabi Uniti 6
EC - Ecuador 6
PH - Filippine 6
PK - Pakistan 6
UA - Ucraina 6
AU - Australia 5
VE - Venezuela 5
ZA - Sudafrica 5
AZ - Azerbaigian 3
BY - Bielorussia 3
CH - Svizzera 3
GT - Guatemala 3
HR - Croazia 3
JM - Giamaica 3
PR - Porto Rico 3
PY - Paraguay 3
SA - Arabia Saudita 3
TH - Thailandia 3
UZ - Uzbekistan 3
AL - Albania 2
BE - Belgio 2
CL - Cile 2
ET - Etiopia 2
HN - Honduras 2
KE - Kenya 2
LT - Lituania 2
MQ - Martinica 2
MY - Malesia 2
PA - Panama 2
PS - Palestinian Territory 2
BH - Bahrain 1
BM - Bermuda 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
HT - Haiti 1
HU - Ungheria 1
IR - Iran 1
KY - Cayman, isole 1
LU - Lussemburgo 1
LV - Lettonia 1
MA - Marocco 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PE - Perù 1
PT - Portogallo 1
QA - Qatar 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 3.899
Città #
Dallas 348
Ashburn 177
Singapore 165
Hefei 104
San Jose 98
Milan 83
Santa Clara 75
Hong Kong 73
Council Bluffs 57
Ho Chi Minh City 47
Beijing 45
Rome 45
Los Angeles 40
Boardman 33
Hanoi 33
New York 31
Atlanta 28
Abidjan 26
Bengaluru 25
Buffalo 25
Lauterbourg 25
Helsinki 24
Guangzhou 23
Moscow 22
Frankfurt am Main 20
Seoul 15
Bologna 14
Chandler 14
Palermo 14
Paris 13
Toronto 13
Denver 11
Florence 11
Genoa 11
São Paulo 11
Chicago 10
Montreal 10
Phoenix 10
Amsterdam 9
Da Nang 9
Naples 9
Shanghai 9
Turin 9
Stockholm 8
The Dalles 8
Cairo 7
Changsha 7
Jakarta 7
London 7
Orem 7
Padua 7
Warsaw 7
Brescia 6
Coccaglio 6
Dublin 6
Mexico City 6
Reggio Emilia 6
Tokyo 6
Washington 6
Abu Dhabi 5
Ancona 5
Bari 5
Guarulhos 5
Pescara 5
Philadelphia 5
Shenzhen 5
Winnipeg 5
Brasília 4
Brooklyn 4
Charlotte 4
Chennai 4
Cleveland 4
Columbus 4
Dhaka 4
Guayaquil 4
Haiphong 4
La Prairie 4
Lappeenranta 4
Ribeirão Preto 4
Rocca Priora 4
San Canzian d'Isonzo 4
Seattle 4
Vienna 4
Baku 3
Bandung 3
Bangkok 3
Barcelona 3
Barnet 3
Bergamo 3
Biên Hòa 3
Bogotá 3
Boston 3
Bremen 3
Chongqing 3
Elk Grove Village 3
Fuzhou 3
Guadalajara 3
Guatemala City 3
Hangzhou 3
Hillsboro 3
Totale 2.136
Nome #
Statins, ACE/ARBs drug use, and risk of pneumonia in hospitalized older patients: a retrospective cohort study 470
Clinical features and outcomes of elderly hospitalised patients with chronic obstructive pulmonary disease, heart failure or both 360
Prescription of ACE-Is/ARBs in patients with cardio-renal disease: a multicenter retrospective cohort study from the REPOSI registry 267
Interaction between lifestyle changes and PNPLA3 genotype in NAFLD patients during the COVID-19 lockdown 227
An Overview of Hepatocellular Carcinoma Surveillance Focusing on Non-Cirrhotic NAFLD Patients: A Challenge for Physicians 195
What Not to Overlook in the Management of Patients with Type 2 Diabetes Mellitus: The Nephrological and Hepatological Perspectives 169
Prescription appropriateness of anti-diabetes drugs in elderly patients hospitalized in a clinical setting: evidence from the REPOSI Register 133
Procoagulant imbalance is associated with hepatic and vascular complications in patients with MASLD and diabetes. Key role of factor VIII 130
Metabolic factors drive early increase in hepatic steatosis despite improvement in non-invasive fibrosis markers after hepatitis C eradication with direct-acting antivirals 130
Association of MASLD Phenotypes With Liver Fibrosis in Hepatitis C: The Role of Cardiometabolic Risk Factors 124
MAFLD and NAFLD: is there the need for redefining the risk of cardiovascular disease and mortality? 119
Remdesivir-induced bradycardia in patients hospitalized with SARS-CoV2 infection: a possible vagally-mediated mechanism 115
Comparison of the severity of metabolic, liver and cardiovascular damage in NAFLD patients attending the hepatology clinic over the last three decades 115
Metabolic dysfunction-associated steatohepatitis exhibits sex differences in people with HIV 112
Minimally invasive trans-sulcal parafascicular surgery for the early evacuation of spontaneous intracerebral hemorrhage: the ENRICH trial 109
Nutritional and Lifestyle Therapy for NAFLD in People with HIV 104
Next Generation Sequencing Allows Identification of a Novel Mutation in the TfR2 Gene and Outperforms the Conventional Diagnostic Techniques 98
Beyond the HIV Organ Policy Equity Act: Roadmap to expanding kidney and liver transplants for people with human immunodeficiency virus utilizing grafts from donors with human immunodeficiency virus 80
Metabolic dysfunction-associated steatotic liver disease: An opportunity for collaboration between cardiology and hepatology 78
The effect of weight gain and metabolic dysfunction-associated steatotic liver disease on liver fibrosis progression and regression in people with HIV 78
Sex differences in the prevalence and cardiometabolic risk profiles of steatotic liver disease: A Canadian Longitudinal Study on Aging analysis 77
Material deprivation is associated with liver stiffness and liver-related outcomes in people with HIV 74
Unnecessary use of proton pump inhibitors in patients discharged on oral anticoagulant therapy: data from the REPOSI registry 73
The role of noninvasive biomarkers for monitoring cell injury in advanced liver fibrosis 69
Discrete Choice Experiments and Conjoint Analyses in Health Screening Programs for Type 2 Diabetes and Liver Disease: A Scoping Review 69
Role of fatty liver in the epidemic of advanced chronic liver disease among people with HIV: protocol for the Canadian LIVEHIV multicentre prospective cohort 65
Inclusive healthcare in light of the new MASLD guidelines: Should people living with HIV be screened for liver fibrosis? 56
Diagnostic Accuracy of Non-Invasive Tests for MASLD Across Age, Type 2 Diabetes, and Obesity Subgroups: A Multinational Study 55
Prescribing cascades among hospitalized older adults: a retrospective cohort study from the REPOSI registry 41
Lifestyle first: tackling MASLD in people living with HIV 41
Predictors of fibrosis, clinical events and mortality in MASLD: Data from the Global-MASLD study 40
Letter to the Editor: People living with HIV and NAFLD-A population left behind in the global effort for liver fibrosis screening? 38
Low lysosomal acid lipase activity is associated with histological progression of metabolic dysfunction-associated steatotic liver disease 35
Global performance of non-invasive tests in MASLD: Insights from the G-MASLD study 34
Metabolic dysfunction associated steatotic liver disease (MASLD) treatment: Does lifestyle still matter? 33
Glucagon-Like Peptide-1 Receptor Agonists and Hepatocellular Carcinoma Prevention: A Meta-Analysis and Clinical Decision Framework 25
Totale 4.038
Categoria #
all - tutte 9.224
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.224


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202210 0 0 0 0 0 0 0 1 0 0 0 9
2022/202339 3 6 3 4 2 4 3 5 4 2 1 2
2023/202451 1 3 1 1 20 3 2 1 1 0 5 13
2024/2025555 12 51 19 49 58 43 55 42 39 49 63 75
2025/20263.383 206 535 368 302 219 143 235 166 274 211 364 360
Totale 4.038